home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Insight Into Devastating Pregnancy Condition

  May, 15 2008 9:40
your information resource in human molecular genetics

Pre-eclampsia is a devastating condition that can erupt towards the end of pregnancy, with life-threatening consequences for mother and baby. A paper published online in Nature has identified two culprits likely to trigger pre-eclampsia if they are in short supply, opening up the possibilities of early diagnosis and even treatment of the disorder.

Raghu Kalluri and colleagues genetically engineered a pre-eclampsia-like condition in mice by preventing them from producing an enzyme called catechol-O-methyltransferase (COMT), which normally inactivates a class of neurotransmitters known as catecholamines. They found that the mice also failed to produce 2-methoxyoestradiol, a natural metabolite produced by COMT that normally increases during the last three months of human pregnancy.

This correlates with women with severe pre-eclampsia, whose levels of COMT and 2-methoxyoestradiol tend to be low. The authors hope that their discovery may assist diagnosis of the condition with a simple blood or urine test. They suggest that supplementation with 2-methoxyoestradiol might improve or possibly prevent pre-eclampsia.

Author contact:

Raghu Kalluri (Harvard Medical School, Boston, MA, USA)
E-mail: rkalluri@bidmc.harvard.edu

Abstract available online.

(C) Nature press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.